Zenas Biopharma Inc. (zbio 2.5 04/01/32)
13F holders, Q1 2026 (March 31)2holders
$1.02avg. 13F price*
At the end of Q1 2026, 2 institutions reported holding Zenas Biopharma Inc. (zbio 2.5 04/01/32) in their 13F filings. The largest holders were Monashee Investment Management LLC ($3.2M) and Maven Securities LTD ($1.6M).
- Company
- Zenas Biopharma Inc. (zbio 2.5 04/01/32)
- CUSIP
- 98937LAA3
- Latest filing quarter
- Q1 2026
Total Exit/New Position Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $4.8M |
| Exits | 0 | $0 |
Ownership 2 holders
| Monashee Investment Management LLC | 2.07% | New | 3,152,000 | $3.2M |
| Maven Securities LTD | 0.09% | New | 1,500,000 | $1.6M |
"% of holder's portfolio" is ZENAS BIOPHARMA INC (ZBIO 2.5 04/01/32)'s weight in each manager's 13F, not the share of Zenas Biopharma Inc. (zbio 2.5 04/01/32) the manager owns.